JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
-
-
-
-
-
-
Form SC 13G AMICUS THERAPEUTICS, Filed by: JPMORGAN CHASE & CO
-
-
-
-
-
-
-
Amicus Therapeutics Reports Preliminary 2022 Revenue and Provides 2023 Strategic Outlook
-
-
-
-
-
-
-
Amicus Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Amicus Therapeutics (FOLD) Defended By JPMorgan, Weakness Overdone Said By Analyst
-
-
-
-
-
-
-
Pre-Open Movers 05/30: (BURL) (KEYS) (BITA) Higher; (JILL) (VVUS) (APTO) (more...)
-
-
-
-
-
-
-
Pre-Open Movers 08/17: (IZEA) (ZOES) (JWN) Higher; (ZN) (VNET) (DF) Lower (more...)
-
-
-
-
-
-
-
Amicus Therapeutics Provides Full-Year 2018 Strategic Outlook and Financial Guidance
-
287,702 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

